Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site’s release/version indicator for the ClinicalTrials.gov study page has been updated from v3.5.2 to v3.5.3, reflecting a platform or content release change rather than any modification to the study details.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedThe study status changed from Recruiting to Active, not recruiting. Several study contact details and names were removed from the page.SummaryDifference3%

- Check51 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to study content.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision: v3.4.2 is now displayed and the prior government funding status notice has been removed. The page’s primary study details and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.